CN110396525A - RNF213 gene completely knocks out the preparation method and purposes of homozygote zebra fish - Google Patents
RNF213 gene completely knocks out the preparation method and purposes of homozygote zebra fish Download PDFInfo
- Publication number
- CN110396525A CN110396525A CN201910592731.2A CN201910592731A CN110396525A CN 110396525 A CN110396525 A CN 110396525A CN 201910592731 A CN201910592731 A CN 201910592731A CN 110396525 A CN110396525 A CN 110396525A
- Authority
- CN
- China
- Prior art keywords
- gene
- rnf213a
- seq
- talen
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000252212 Danio rerio Species 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 101100144674 Homo sapiens RNF213 gene Proteins 0.000 title description 13
- 238000010459 TALEN Methods 0.000 claims abstract description 39
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 claims abstract description 39
- 239000013612 plasmid Substances 0.000 claims abstract description 21
- 208000009433 Moyamoya Disease Diseases 0.000 claims abstract description 19
- 101150035732 rnf213a gene Proteins 0.000 claims abstract description 17
- 241000251468 Actinopterygii Species 0.000 claims abstract description 13
- 108020004999 messenger RNA Proteins 0.000 claims abstract description 13
- 210000001161 mammalian embryo Anatomy 0.000 claims abstract description 11
- 201000011066 hemangioma Diseases 0.000 claims abstract description 10
- 101000584881 Danio rerio E3 ubiquitin-protein ligase rnf213-alpha Proteins 0.000 claims abstract description 9
- 206010064571 Gene mutation Diseases 0.000 claims abstract description 9
- 238000013461 design Methods 0.000 claims abstract description 8
- 238000000338 in vitro Methods 0.000 claims abstract description 8
- 230000002068 genetic effect Effects 0.000 claims abstract description 5
- 238000002347 injection Methods 0.000 claims abstract description 4
- 239000007924 injection Substances 0.000 claims abstract description 4
- 230000035772 mutation Effects 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 11
- 125000003729 nucleotide group Chemical group 0.000 claims description 11
- 230000029087 digestion Effects 0.000 claims description 10
- 238000001712 DNA sequencing Methods 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 3
- 238000003209 gene knockout Methods 0.000 claims description 3
- 230000009261 transgenic effect Effects 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 13
- 238000005516 engineering process Methods 0.000 abstract description 7
- 238000010362 genome editing Methods 0.000 abstract description 2
- 238000007877 drug screening Methods 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 239000007788 liquid Substances 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 11
- 102100027418 E3 ubiquitin-protein ligase RNF213 Human genes 0.000 description 9
- 101000650316 Homo sapiens E3 ubiquitin-protein ligase RNF213 Proteins 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 8
- 238000011160 research Methods 0.000 description 7
- 239000002699 waste material Substances 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000001376 precipitating effect Effects 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- KVYVOGYEMPEXBT-GUBZILKMSA-N Gln-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O KVYVOGYEMPEXBT-GUBZILKMSA-N 0.000 description 4
- PRBLYKYHAJEABA-SRVKXCTJSA-N Gln-Arg-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O PRBLYKYHAJEABA-SRVKXCTJSA-N 0.000 description 4
- HTTSBEBKVNEDFE-AUTRQRHGSA-N Glu-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)N HTTSBEBKVNEDFE-AUTRQRHGSA-N 0.000 description 4
- DLISPGXMKZTWQG-IFFSRLJSSA-N Glu-Thr-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O DLISPGXMKZTWQG-IFFSRLJSSA-N 0.000 description 4
- LYCVKHSJGDMDLM-LURJTMIESA-N His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CC1=CN=CN1 LYCVKHSJGDMDLM-LURJTMIESA-N 0.000 description 4
- QKIBIXAQKAFZGL-GUBZILKMSA-N Leu-Cys-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O QKIBIXAQKAFZGL-GUBZILKMSA-N 0.000 description 4
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 4
- JDBQSGMJBMPNFT-AVGNSLFASA-N Leu-Pro-Val Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O JDBQSGMJBMPNFT-AVGNSLFASA-N 0.000 description 4
- KLSUAWUZBMAZCL-RHYQMDGZSA-N Leu-Thr-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(O)=O KLSUAWUZBMAZCL-RHYQMDGZSA-N 0.000 description 4
- LTFLDDDGWOVIHY-NAKRPEOUSA-N Val-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N LTFLDDDGWOVIHY-NAKRPEOUSA-N 0.000 description 4
- 108010036413 histidylglycine Proteins 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 108010070643 prolylglutamic acid Proteins 0.000 description 4
- 230000003252 repetitive effect Effects 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- KLALXKYLOMZDQT-ZLUOBGJFSA-N Ala-Ser-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(N)=O KLALXKYLOMZDQT-ZLUOBGJFSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 101100086288 Danio rerio rnf213a gene Proteins 0.000 description 3
- 108010042407 Endonucleases Proteins 0.000 description 3
- 102000004533 Endonucleases Human genes 0.000 description 3
- 108700019146 Transgenes Proteins 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 108091033409 CRISPR Proteins 0.000 description 2
- 101100540419 Danio rerio kdrl gene Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- 241000446313 Lamella Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000004298 cerebral vein Anatomy 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Chemical compound NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 2
- 108010015792 glycyllysine Proteins 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- NHWYNIZWLJYZAG-XVYDVKMFSA-N Ala-Ser-His Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N NHWYNIZWLJYZAG-XVYDVKMFSA-N 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- OMMIEVATLAGRCK-BYPYZUCNSA-N Asp-Gly-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)NCC(O)=O OMMIEVATLAGRCK-BYPYZUCNSA-N 0.000 description 1
- 238000010354 CRISPR gene editing Methods 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- QITBQGJOXQYMOA-ZETCQYMHSA-N Gly-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)CN QITBQGJOXQYMOA-ZETCQYMHSA-N 0.000 description 1
- CDGLBYSAZFIIJO-RCOVLWMOSA-N Ile-Gly-Gly Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O CDGLBYSAZFIIJO-RCOVLWMOSA-N 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101100144675 Mus musculus Rnf213 gene Proteins 0.000 description 1
- 101150016062 Rnf213 gene Proteins 0.000 description 1
- 231100000768 Toxicity label Toxicity 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 206010002906 aortic stenosis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 108010021843 fluorescent protein 583 Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000003197 gene knockdown Methods 0.000 description 1
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000011813 knockout mouse model Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 210000001202 rhombencephalon Anatomy 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
- A01K2217/077—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out heterozygous knock out animals displaying phenotype
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/40—Fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0331—Animal model for proliferative diseases
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Environmental Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses preparations and its application that a kind of rnf213a gene completely knocks out zebra fish mutant;Design is directed to the TALEN sequence of zebra fish rnf213a gene;Its left and right arms plasmid is constructed, and corresponding mRNA is transcribed in vitro out;TALEN left and right arms mRNA is mixed and is injected into zebrafish embryo;Embryo after injection supports to F0 adult fish and mates with wild type adult fish, and the embryo for carrying rnf213a gene mutation is supported to F1 adult fish;F1 generation fish cuts coda gene type identification discovery, and there are two kinds of heterozygote genotypes :+2bp and -7bp;By heterozygote and wild type adult fish diplomatic 3 generations, after purifying its genetic background, then the heterozygote crosses of syngeneic type are obtained into two kinds of genotype of homozygote :+2bp and -7bp.The embryo that homozygote hybridizes with homozygote carries out Phenotypic Observation discovery and there is Moyamoya Disease phenotype similar with people and cvernous hemangioma phenotype.The present invention can rapidly and efficiently establish rnf213a gene and completely strike zebra fish strain by TALEN gene editing technology, can carry out the drug screening work for Moyamoya Disease or/and cvernous hemangioma using the model.
Description
Technical field
The invention belongs to gene engineering technology fields, more particularly to are beaten using gene and technology is knocked out zebra fish rnf213a
The method of gene.
Background technique
RNF213 gene is located at No. 17 chromosomes, and coding includes the ring finger protein of 5207 amino acid, and there are two the genes
Important functional areas RING finger domain and AAA+ATPases domain.In recent years, RNF213 caused concern main
It is because research discovery RNF213 is the tumor susceptibility gene of East Asia crowd's Moyamoya Disease, especially Japanese;The research in later period also found
Gene point mutation p.R4810K is also related with asian population encephalic aortic stenosis;One research in Europe finds RNF213
Different loci mutation is also related to Caucasian's aneurysm.RNF213 gene may be related to a variety of cerebrovascular pathogenesis.
RNF213 p.R4810K is related to Moyamoya Disease, and there are obvious racial differences, are concentrated mainly on Asian, Japanese smog
Patient's site mutation rate is 90.1%, South Korea 78.9%, China 23.1%;There is also the variation in the site, days by normal person
I 2.5%, and Korean 2.7%, and Chinese 0.9%.Relative to Japan and South Korea, this mutation position of Chinese Han nationality's Moyamoya Disease patient
Mutations in epithelial is lower.Caucasian's Moyamoya Disease disease incidence is Japanese 1/10, and Caucasian does not have found RNF213 p.R4810K
Obviously related to Moyamoya Disease, this may be lower one of the reason of Caucasian's Moyamoya Disease disease incidence.In RNF213 p.R4810K
It is found with the research of identical environment difference blood lineage Moyamoya Disease patient, p.R4810K is deposited in 56% Asian ancestry Moyamoya Disease patient
Without p.R4810K point mutation in non-Asian ancestry Moyamoya Disease patient.Whether this prompt RNF213 p.R4810K participates in Moyamoya Disease
Pathogenesis there are racial differences.
In the research of translational medicine, there is the life of part vascular bud, similar smog in zebra fish rnf213 gene knockdown
The vascular bud of disease is raw;Utilize the phenotype of the 32 non-simulation smoke disease of exon of cre-loxp system knock-out mice Rnf213 gene;
The phenotype of corresponding people RNF213c.14429G > A point mutation mouse also non-simulation smoke disease.Whether RNF213 takes part in Moyamoya Disease
Pathogenesis still has dispute.
It found to strike using morpholino technology in recent years and subtracts related gene and be easy to appear phenotype, but phenotype is in mutant
Can not repeat, research shows that morpholino technology be easy to appear miss the target knock out other genes to cause phenotype specificity compared with
Difference.
Summary of the invention
It provides and is completely knocked out using TALEN technology it is an object of the invention to overcome above-mentioned the deficiencies in the prior art place
Zebra fish rnf213a gene, the target spot of design are 2 exons of zebra fish rnf213a, and pass through the interior friendship again of diplomatic 3 generations
Form homozygote zebra fish.By observing the phenotype of homozygous mutation body, caused by avoidable injection and morpholino miss the target
False phenotype increases the specificity of phenotype.
To achieve the above object, the technical scheme adopted by the invention is as follows:
A kind of RNF213 gene completely knocks out the preparation method of homozygote zebra fish, comprising the following steps:
S1, design are directed to the TALEN sequence of 2 exon target sequence of zebra fish RNF213 gene;
S2, the building left and right arm plasmid of TALEN, and the left and right arm mRNA of TALEN is transcribed in vitro out respectively;
S3, the left and right arm mRNA of TALEN is mixed and is injected into transgenic zebrafish embryo, extract embryo's DNA sequencing hair
The mRNA of existing TALEN can act on 2 exon of rnf213a gene;
S4, it mates by the Embryo Culture after injection to F0 generation, and with wild type adult fish, obtains F1 generation adult fish;
S5, identification F1 whether there is rnf213a gene mutation, and identify rnf213a gene mutation type through DNA sequencing,
By the heterozygote containing rnf213a gene mutation and wild type diplomatic 3 generations, its genetic background is purified;
S6, the heterozygote crosses of syngeneic type are obtained to two kinds of genotype of homozygote :+2bp and -7bp.
Preferably, the 2 exon target sequence of zebra fish RNF213 gene in the step S1 is SEQ ID NO.1 institute
Show.
Preferably, the left arm sequence of the TALEN sequence in the step S1 is as shown in SEQ ID NO.2;Right arm sequence is such as
Shown in SEQ ID NO.3.
Preferably, the TALEN sequence in the step S1 further includes the nucleotide sequence and its volume that can identify different bases
The amino acid sequence of code, wherein the amino acid sequence that the nucleotide sequence of identification base A as shown in SEQ ID NO.4, encodes
As shown in SEQ ID NO.5;The nucleotide sequence of base T is identified as shown in SEQ ID NO.6, the amino acid sequence of coding is such as
Shown in SEQ ID NO.7;The nucleotide sequence of base C is identified as shown in SEQ ID NO.8, the amino acid sequence of coding is such as
Shown in SEQ ID NO.9;The nucleotide sequence of bases G is identified as shown in SEQ ID NO.10, the amino acid sequence of coding is such as
Shown in SEQ ID NO.11.
Preferably, further include the competent cell for the plasmid conversion low-copy that will be constructed in the step S2, expanded
After culture, plasmid is extracted, is identified through restricted interior digestion DNA sequencing, determines plasmid dna sequence.
Preferably, the forward primer for plasmid order-checking design is as shown in SEQ ID NO.12;Reverse primer such as SEQ
Shown in ID NO.13.
Preferably, the identified adult fish F1 heterozygote containing rnf213a gene mutation is+2bp mutation in the step S5
Body and -7bp mutant
Preferably, homozygote is respectively+2bp mutant and -7bp mutant in the step S6.
The homozygous preparation side of RNF213 gene knockout zebra fish mutant that the present invention also provides a kind of according to
The RNF213 gene knockout zebra fish mutant homozygosis submodel that method is established is as Moyamoya Disease or/and cvernous hemangioma
Medicaments sifting model in purposes.
Beneficial effects of the present invention: the present invention completely knocks out zebra fish rnf213a base by TALEN gene editing technology
It is lower to knock out the probability that misses the target relative to CRISPR/Cas9 system gene for cause.Generally there are transgene backgrounds for rnf213a mutant
Tg (flk1:eGFP/gata1:DsRed) has red green fluorescence, such as: red-label red blood cell, Green Marker blood vessel endothelium,
But through the invention diplomatic 3 generations again in hand over the homozygous mutation body obtained, reduce genetic background.The present invention obtains
Two kinds of genotype that rnf213a is completely knocked out, phenotype can be verified in two kinds of genotype simultaneously, increase the specificity of phenotype.
The rnf213a gene mutation body that the present invention constructs can be used as the zebra fish animal model of Moyamoya Disease and cvernous hemangioma.
Detailed description of the invention
Fig. 1 is that (wherein A is TALEN2 exon nucleotide for the sequencing result of F1 generation+2bp of the present invention and -7bp mutant
Sequence and target spot;B is+2bp mutant sequencing result;C is -7bp mutant sequencing result);
Fig. 2 is to pass through laser lamella microscope and the micro- sem observation rnf213a of single photon-/-The observation result of phenotype is (wherein
A-C expression+2bp, -7bp mutation type surface are similar to Moyamoya Disease;D-F expression+2bp, -7bp mutation type surface are similar to the spongy of people
Hemangioma).
Specific embodiment
For more concise displaying technical solution of the present invention, objects and advantages, combined with specific embodiments below
And its attached drawing is described in further detail the present invention.
Embodiment
1, the shot design of TALEN
(1) sequence of 2 exon of zebra fish rnf213a gene is obtained in Pubmed database.It is designed according to TALEN former
Then, it using TALEN sequence special designing software, is designed for 2 exon of rnf213a gene.Share 8 kinds of TALEN bones
Frame carrier, left and right arms each 4, they contain NLS, N-terminal, the basic structures such as C-terminal and Fok I.In the serial carrier, in advance
It assembles in TALE repetitive structure domain, last 0.5 repetitive unit at 3 ' ends, also known as half site (Half-site).It can be special
Identify to property the last one base of TALEN target spot.According to the difference of identification A/T/C/G base, it is divided into left arm L1/L2/L3/
L4, right arm L1/L2/L3/L4.
(2) for the TALEN left arm sequence of 2 exon of zebra fish rnf213a gene design are as follows: 5 '-
CTGCAGTGAGTGTGGACAT-3 ', TALEN right arm sequence: 5 '-TACGAGACAACACAAGGT-3 ';Zebra fish RNF213 base
Because of the target sequence of 2 exons are as follows: 5 '-TAAACTGCAATCTCAA-3 '.
2, the building of TALEN expression vector
(1) it is completed according to block coupled in series building block principle using TALEN kit (Shanghai Si Dansai biology Co., Ltd)
The building of TALEN expression vector, specific steps are as follows: by identification last T of the sequence removal of TALEN left and right arms, with one or two
A base composition is as a module, first label, the last one is labeled as 9, and so on be marked.
(2) 9 modules accordingly numbered are taken out, each module takes 1.5ul, and is added into the same PCR pipe.It is shared
8 kinds of TALEN skeleton carriers, left and right arms each 4, they contain NLS, N-terminal, the basic structures such as C-terminal and Fok I.The series carries
In body, in pre-assembly TALE repetitive structure domain, last 0.5 repetitive unit at 3 ' ends, also known as half site (Half-
site).It can specifically identify the last one base of TALEN target spot.According to the difference of identification A/T/C/G base, it is divided into a left side
Arm L1/L2/L3/L4, right arm R1/R2/R3/R4, structure are as shown in table 1.
Table 1: the structural representation of left arm L1/L2/L3/L4 and right arm R1/R2/R3/R4
(3) it is loaded by 2 reaction system of table, corresponding TALEN skeleton carrier is first added, then by solution 3, solution 1, solution
2 sequentially add in PCR pipe, and finally plus water is mended to 20ul, mix, gently get rid of.
Table 2: left and right arm TALEN coupled reaction system
Above-mentioned reaction condition is as follows
(4) it takes out PCR pipe and 4 1ul of solution, 5 0.5ul of solution (solution 5 asks 37 DEG C to melt in advance) is added, mix, In
It is incubated for one hour for 37 DEG C in PCR instrument or water-bath.
(5) it by the EP pipe of final product conversion competent cell containing low-copy, mixes, places 30min on ice, then
It is put into heat shock 45s in 42 DEG C of water-baths, then is placed in 3min on ice rapidly.500ulSOC solution is added into EP pipe, is placed in 37
DEG C, 30min is cultivated in the shaking table of 250rpm.After taking out EP pipe, 5min is centrifuged in the centrifuge of 4000r/min.Discard EP pipe
In most of supernatant, leave about 100ul, and will precipitating gently piping and druming mixes, be spread evenly across card and receive the plate of chloramphenicol resistance
In, it is inverted in 37 DEG C of incubators and is incubated overnight 12-16 hours.
3, plasmid extracts
(1) it is operated using small amount plasmid extraction kit, single colonie in picking culture plate, is inoculated into that is mould containing card
In the 5ml LB culture medium of element, 37 DEG C of constant-temperature table 250rpm shaken overnight cultures.
(2) to reduce recombination fraction, the competent bacteria of low-copy is selected in this research.When extracting plasmid, each clone is at least
Extract 4ml bacterium solution.After bacterium solution to be poured into the EP pipe of 1.5ml, 12000rpm is centrifuged 30 seconds at 4 DEG C, collects precipitating.Supernatant is removed,
The solution P1 of 250ul pre-cooling is added, is vibrated in vortex oscillator, until bacterial sediment is broken up completely.250ul solution is added
P2 mildly reverse centrifuge tube 5 times, mixes content, is sure not to vibrate.The solution P3 for adding 350ul to be pre-chilled is overturned for several times repeatedly, can
See that White Flocculus occurs.12000rpm is centrifuged 10 minutes at 4 DEG C, abandons precipitating.Supernatant is transferred in adsorption column CP3, is stood
10 minutes.4 DEG C of 12000rpm are centrifuged 1 minute, outwell the waste liquid in collecting pipe.500l protein liquid removal PD is added into adsorption column,
12000rpm is centrifuged 30-60sec, outwells the waste liquid in collecting pipe, adsorption column CP3 is put back in collecting pipe.Add to adsorption column CP3
Enter 600l rinsing liquid PW, 12,000rpm centrifugation 30-60sec outwell the waste liquid in collecting pipe, adsorption column CP3 is put into collecting pipe
In, it washes repeatedly 1 time.Last 12,000rpm is centrifuged 2min, and rinsing liquid remaining in adsorption column is removed.Adsorption column CP3 is opened
Lid, is placed in and is placed at room temperature for several minutes, dry rinsing liquid remaining in adsorption column.It places it in clean centrifuge tube, to absorption
50-100l elution buffer EB is added dropwise among film.It is placed at room temperature for 10min, 12,000rpm centrifugation 2min collect plasmid solution and arrive
In centrifuge tube.
(3) digestion is identified, endonuclease reaction system is as shown in table 3;
Table 3: endonuclease reaction system
It 37 DEG C, reacts 10 minutes.Digestion products 5ul is taken, 6 × loading Buffer 1ul is added, mixes, is loaded onto
In 1.5% Ago-Gel, whether constant pressure 120V electrophoresis 30 minutes, identification digestion are correct at room temperature.
(4) it is sequenced: sending the correct plasmid of digestion to sequencing, and be compared with standard sequence, obtain final correct matter
Grain, by Shanghai, Invitrogen Corp. is completed.Sequencing forward primer is 5 '-CTCCCCTTCAGCTGGACAC-3 ', and reverse primer is
5'-AGCTGGGCCACGATTGAC-3'.The corresponding TALEN DNA sequence dna of different bases and amino acid sequence such as 4 institute of table:
Table 4: corresponding TALEN DNA sequence dna and amino acid sequence with base
4, the left and right arm mRNA of TALEN matter is transcribed in vitro
(1) preparation of template is transcribed in vitro
1) linearize TALEN plasmid (restriction enzyme Not I), using as be transcribed in vitro template.Digestion system such as table 5
It is shown:
Table 5: template reaction system is transcribed in vitro
It 37 DEG C, reacts 2 hours.3 μ l are taken to carry out 1.5% agarose gel electrophoresis, whether digestion is complete with clear plasmid.
2) digestion products purify: Beijing Tiangeng biology Co., Ltd;
Using common purified product kit, product after purification and recovery digestion, detailed step is as follows: into adsorption column CB2
500ul equilibrium liquid BL is added, 12,000rpm centrifugation 1min outwell the waste liquid in collecting pipe, adsorption column CB2 is put back to collecting pipe
In.Into endonuclease reaction liquid, 5 times of volume combination liquid PB are added, mix well.Acquired solution is added in adsorption column CB2, room temperature
10min is placed, 12,000rpm centrifugation 30-60sec outwell the waste liquid in collecting pipe, adsorption column CB2 is put into collecting pipe.To
600ul rinsing liquid PW is added in adsorption column CB2,12,000rpm centrifugation 30-60sec abandon waste liquid, adsorption column CB2 is put into collection
Guan Zhong.Repeated washing is primary.Adsorption column CB2 is put back in collecting pipe, 12,000rpm centrifugation 2min, as far as possible removing rinsing liquid.It will
Adsorption column CB2 is placed several minutes in room temperature, is thoroughly dried.Finally adsorption column CB2 is put into clean centrifuge tube, to suction
The hanging 30ulDEPC that is added dropwise handles water among membrane, is placed at room temperature for 5min.12,000rpm is centrifuged 2min and collects solution.
3) measurement of template plasmid concentration
The eluent TE for taking sample 2ul that 98ul is added is detected under ssDNA mode with Nano drop spectrophotometer.
Testing result shows that OD260/OD280 between 1.7-1.9, illustrates that purity is preferable.
(2) it is transcribed in vitro: Life Techologies company;
Using mMessagemMachine SP6kit kit, mRNA synthetic reaction is carried out.Reaction system is as shown in table 6:
Table 6:mRNA synthetic reaction system
According to plasmid concentration adjust additional amount, guarantee plasmid template total amount 1ug, after mixing gently, 37 DEG C water-bath 2 hours.
Add 1ul TURBO Dnase, 37 DEG C of water-bath 15min is mixed, to eliminate DNA profiling.
(3) purifying (lithium chloride precipitating) of transcription product
Using mMessagemMachine SP6kit kit, mRNA purifying and resuspension are carried out, by reagent: 20 μ l of RNA;
Licl 30μl;30 μ l of Nuclease Free water, after mixing, -20 DEG C of precipitatings are greater than 30min, 4 DEG C of 13200rpm centrifugations
15min, goes supernatant (paying attention to EP bottom of the tube RNA precipitate), the cleaning of 70% ethyl alcohol of 1ml, and 4 DEG C of centrifugation 15min of 13200rpm are gone
Clearly.Nuclease Free water is added after slightly drying, RNA is resuspended, after measuring concentration, packing, -80 DEG C of preservations.
4, it injects, identification and hybridization
(1) by the mRNA mixture of the left and right arm of TALEN of final concentration of 400ng/ μ l be injected into 10 have Tg (flk1:
Egfp/gata1:dsRed it) in the zebrafish embryo of transgene background, supports to adult fish and obtains F0 generation, then by F0 for adult fish and open country
Raw type zebra fish mating, obtains heterozygote F1 generation, F1 is carried out genomic DNA sequencing, identification obtains+2bp mutant and -7bp
Mutant heterozygote, wherein there are 6 embryos to be mutated, mutation efficiency 60%.
(2) in order to purify transgene genetic background, respectively by the heterozygote and wild type of two kinds of mutant of+2bp and -7bp
Zebra fish mated for 3 generations, obtained F2.
(3)+2bp mutant is mated with+2bp mutant respectively, -7bp mutant mates with -7bp mutant, finally obtains
Obtain RNF213 gene completely knockout+2bp mutant homozygote and -7bp mutant homozygote.
5, phenotype is observed
By laser lamella microscope and the micro- sem observation rnf213a- of single photon/- phenotype, find mutant (+2bp:
49.4%;- 7bp:46.4%) in rear cerebral veins, venae cerebri, there are the vascular buds of similar smoke-like to give birth to original hindbrain traffic intersection, and it should
Phenotype is similar to Moyamoya Disease (such as Fig. 2A-C);More importantly occur between rear cerebral veins, venae cerebri mulberries sample vascular bud it is raw (+2bp:
69.4%;- 7bp:71.4%), the phenotype similar to people cvernous hemangioma (such as Fig. 2 D-F), further in cvernous hemangioma
Patient tests and is confirmed, it was confirmed that RNF213 gene is the tumor susceptibility gene of cvernous hemangioma.The two phenotypes are equal
It is confirmed in two kinds of genotype (+2bp and -7bp), further demonstrates the specificity of RNF213 gene and phenotype.Therefore should
Genotype zebra fish (rnf213a-/-) can be used as the zebra fish animal model of cvernous hemangioma and Moyamoya Disease.
The embodiments described above only express several embodiments of the present invention, and the description thereof is more specific and detailed, but simultaneously
It cannot therefore be construed as limiting the scope of the patent.It should be pointed out that coming for those of ordinary skill in the art
It says, without departing from the inventive concept of the premise, various modifications and improvements can be made, these belong to protection of the invention
Range.Therefore, the scope of protection of the patent of the invention shall be subject to the appended claims.
SEQUENCE LISTING
<110>No.1 Hospital Affiliated to Zhongshan Univ.
<120>RNF213 gene completely knocks out the preparation method and purposes of homozygote zebra fish
<130> 7.2
<160> 13
<170> PatentIn version 3.3
<210> 1
<211> 16
<212> DNA
<213>it synthesizes
<400> 1
taaactgcaa tctcaa 16
<210> 2
<211> 19
<212> DNA
<213>it synthesizes
<400> 2
ctgcagtgag tgtggacat 19
<210> 3
<211> 18
<212> DNA
<213>it synthesizes
<400> 3
tacgagacaa cacaaggt 18
<210> 4
<211> 102
<212> DNA
<213>it synthesizes
<400> 4
ctcactccgg aacaagtggt cgcaatcgcc tccaacattg gcgggaaaca ggcactcgag 60
actgtccagc gcctgcttcc cgtgctgtgc caagcgcacg gt 102
<210> 5
<211> 34
<212> PRT
<213>it synthesizes
<400> 5
Leu Thr Pro Glu Gln Val Val Ala Ile Ala Ser Asn Ile Gly Gly Lys
1 5 10 15
Gln Ala Leu Glu Thr Val Gln Arg Leu Leu Pro Val Leu Cys Gln Ala
20 25 30
His Gly
<210> 6
<211> 102
<212> DNA
<213>it synthesizes
<400> 6
ctgaccccag agcaggtcgt ggccattgcc tcgaatggag ggggcaaaca ggcgttggaa 60
accgtacaac gattgctgcc ggtgctttgt caggcacacg gc 102
<210> 7
<211> 34
<212> PRT
<213>it synthesizes
<400> 7
Leu Thr Pro Glu Gln Val Val Ala Ile Ala Ser Asn Gly Gly Gly Lys
1 5 10 15
Gln Ala Leu Glu Thr Val Gln Arg Leu Leu Pro Val Leu Cys Gln Ala
20 25 30
His Gly
<210> 8
<211> 102
<212> DNA
<213>it synthesizes
<400> 8
ctgaccccag agcaggtcgt ggcgatcgca agccacgacg gaggaaagca agccttggaa 60
acagtacaga ggctgttgcc tgtgctttgt caggcacacg gc 102
<210> 9
<211> 34
<212> PRT
<213>it synthesizes
<400> 9
Leu Thr Pro Glu Gln Val Val Ala Ile Ala Ser His Asp Gly Gly Lys
1 5 10 15
Gln Ala Leu Glu Thr Val Gln Arg Leu Leu Pro Val Leu Cys Gln Ala
20 25 30
His Gly
<210> 10
<211> 102
<212> DNA
<213>it synthesizes
<400> 10
ctcactccgg aacaagtggt cgcaatcgcg agcaataacg gcggaaaaca ggctttggaa 60
acggtgcaga ggctccttcc agtgctgtgc caagcgcacg gt 102
<210> 11
<211> 34
<212> PRT
<213>it synthesizes
<400> 11
Leu Thr Pro Glu Gln Val Val Ala Ile Ala Ser Asn Asn Gly Gly Lys
1 5 10 15
Gln Ala Leu Glu Thr Val Gln Arg Leu Leu Pro Val Leu Cys Gln Ala
20 25 30
His Gly
<210> 12
<211> 19
<212> DNA
<213>it synthesizes
<400> 12
ctccccttca gctggacac 19
<210> 13
<211> 18
<212> DNA
<213>it synthesizes
<400> 13
agctgggcca cgattgac 18
Claims (9)
1. the preparation method that a kind of rnf213a gene completely knocks out homozygote zebra fish, which comprises the following steps:
S1, design are directed to the TALEN sequence of 2 exon target sequence of zebra fish rnf213a gene;
S2, the building left and right arm plasmid of TALEN, and the left and right arm mRNA of TALEN is transcribed in vitro out respectively;
S3, the left and right arm mRNA of TALEN is mixed and is injected into transgenic zebrafish embryo, extract the discovery of embryo's DNA sequencing
The mRNA of TALEN can act on 2 exon of rnf213a gene;
S4, it mates by the Embryo Culture after injection to F0 generation, and with wild type adult fish, obtains F1 generation adult fish;
S5, identification F1 whether there is rnf213a gene mutation, and identify rnf213a gene mutation type through DNA sequencing, will contain
There are heterozygote and wild type diplomatic 3 generations of rnf213a gene mutation, purifies its genetic background;
S6, the heterozygote crosses of syngeneic type are obtained to two kinds of genotype of homozygote :+2bp and -7bp.
2. preparation method as described in claim 1, which is characterized in that the zebra fish rnf213a gene 2 in the step S1
Exon target sequence is shown in SEQ ID NO.1.
3. preparation method as described in claim 1, which is characterized in that the left arm sequence of the TALEN sequence in the step S1
As shown in SEQ ID NO.2;Right arm sequence is as shown in SEQ ID NO.3.
4. preparation method as described in claim 1, which is characterized in that the TALEN sequence in the step S1 further includes that can know
The nucleotide sequence of other different bases and its amino acid sequence of coding, wherein the nucleotide sequence such as SEQ ID of identification base A
Shown in NO.4, the amino acid sequence of coding is as shown in SEQ ID NO.5;Identify the nucleotide sequence such as SEQ ID of base T
Shown in NO.6, the amino acid sequence of coding is as shown in SEQ ID NO.7;Identify the nucleotide sequence such as SEQ ID of base C
Shown in NO.8, the amino acid sequence of coding is as shown in SEQ ID NO.9;Identify the nucleotide sequence such as SEQ ID of bases G
Shown in NO.10, the amino acid sequence of coding is as shown in SEQ ID NO.11.
5. preparation method as described in claim 1, which is characterized in that further include the plasmid conversion that will be constructed in the step S2
The competent cell of low-copy after being expanded culture, extracts plasmid, identifies through restricted interior digestion DNA sequencing, determines plasmid
DNA sequence dna.
6. preparation method as claimed in claim 5, which is characterized in that the forward primer for plasmid order-checking design is such as
Shown in SEQ ID NO.12;Reverse primer is as shown in SEQ ID NO.13.
7. preparation method as described in claim 1, which is characterized in that identified in the step S5 to contain rnf213a gene
The adult fish F1 heterozygote of mutation is+2bp mutant and -7bp mutant.
8. preparation method as described in claim 1, which is characterized in that homozygote is respectively+2bp mutant in the step S6
And -7bp mutant.
9. a kind of rnf213a gene knockout zebra fish mutant homozygosis submodule that preparation method as described in claim 1 is established
Type is as the purposes in the medicaments sifting model for Moyamoya Disease or/and cvernous hemangioma.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910592731.2A CN110396525A (en) | 2019-07-03 | 2019-07-03 | RNF213 gene completely knocks out the preparation method and purposes of homozygote zebra fish |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910592731.2A CN110396525A (en) | 2019-07-03 | 2019-07-03 | RNF213 gene completely knocks out the preparation method and purposes of homozygote zebra fish |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110396525A true CN110396525A (en) | 2019-11-01 |
Family
ID=68323934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910592731.2A Pending CN110396525A (en) | 2019-07-03 | 2019-07-03 | RNF213 gene completely knocks out the preparation method and purposes of homozygote zebra fish |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110396525A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010259390A (en) * | 2009-05-08 | 2010-11-18 | Tohoku Univ | Method for detecting or diagnosing moyamoya disease onset risk by detecting gene mutation |
WO2011049207A1 (en) * | 2009-10-23 | 2011-04-28 | 国立大学法人京都大学 | Moyamoya disease-related gene and utilization of same |
CN108018316A (en) * | 2017-12-20 | 2018-05-11 | 湖南师范大学 | A kind of method of gene knockout selection and breeding rmnd5b Gene Deletion zebra fish |
CN108103108A (en) * | 2018-01-30 | 2018-06-01 | 上海交通大学医学院附属瑞金医院 | Preparation and application of Cebpa gene-deleted zebra fish mutant |
-
2019
- 2019-07-03 CN CN201910592731.2A patent/CN110396525A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010259390A (en) * | 2009-05-08 | 2010-11-18 | Tohoku Univ | Method for detecting or diagnosing moyamoya disease onset risk by detecting gene mutation |
WO2011049207A1 (en) * | 2009-10-23 | 2011-04-28 | 国立大学法人京都大学 | Moyamoya disease-related gene and utilization of same |
CN108018316A (en) * | 2017-12-20 | 2018-05-11 | 湖南师范大学 | A kind of method of gene knockout selection and breeding rmnd5b Gene Deletion zebra fish |
CN108103108A (en) * | 2018-01-30 | 2018-06-01 | 上海交通大学医学院附属瑞金医院 | Preparation and application of Cebpa gene-deleted zebra fish mutant |
Non-Patent Citations (3)
Title |
---|
JUN WEN等: "Mutation of rnf213a by TALEN causes abnormal angiogenesis and circulation defects in zebrafish", 《BRAIN RESEARCH》 * |
YONG-GANG MA等: "Role of Ring Finger Protein 213 in Moyamoya Disease", 《CHIN MED J (ENGL)》 * |
沈延等: "类转录激活因子效应物核酸酶(TALEN)介导的基因组定点修饰技术", 《遗传》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2016204127B2 (en) | Restricted immunoglobulin heavy chain mice | |
US20200032294A1 (en) | Somatic haploid human cell line | |
CN105647969B (en) | Method for breeding zebra fish with stat1a gene deletion by gene knockout | |
Crawford-Miksza et al. | Adenovirus serotype evolution is driven by illegitimate recombination in the hypervariable regions of the hexon protein | |
US6080541A (en) | Method for producing tagged genes, transcripts, and proteins | |
JP2549049B2 (en) | Manufacture of Factor VIII and related products | |
Zhou et al. | Programmable base editing of the sheep genome revealed no genome-wide off-target mutations | |
UA119135C2 (en) | Engineered transgene integration platform (etip) for gene targeting and trait stacking | |
CN109762882B (en) | Probe set and kit for detecting pathogenic gene of primary immunodeficiency disease | |
CN111763687B (en) | Method for rapidly cultivating corn haploid induction line based on gene editing technology | |
CN101440399B (en) | Molecular marking method for indicating and identifying litter size in pigs by MMP23 gene | |
CN109628454A (en) | The construction method of zebra fish glycogen storage disease gys1 and gys2 gene mutation body | |
CN110484549A (en) | Genome targeting modification method | |
Malar C et al. | Haplotype-phased genome assembly of virulent Phytophthora ramorum isolate ND886 facilitated by long-read sequencing reveals effector polymorphisms and copy number variation | |
CN113544257A (en) | Characterization and inactivation of endogenous retroviruses in chinese hamster ovary cells | |
Shimizu et al. | Report of the fifth international workshop on human chromosome 21 mapping 1994 | |
CN109929875A (en) | A kind of construction method of LAG3 gene humanized animal's model and its application | |
CN113106102A (en) | Method for constructing POU4F3 gene deletion type mutant zebra fish animal model | |
CN109136401A (en) | The SNP marker of downy mildew resistance gene BrRLP48 and coupled lock on Chinese cabbage A04 chromosome | |
CN108300738A (en) | A kind of preparation method of the humanized mouse model of the neutrophil leucocyte missing of NOD genetic backgrounds | |
CN110396525A (en) | RNF213 gene completely knocks out the preparation method and purposes of homozygote zebra fish | |
CN106636197B (en) | A method of orientation strikes multi-copy gene in drop zebra fish genome | |
CN106636204B (en) | A kind of albefaction Misgurnus auguillicaudatus breeding method that can stablize heredity | |
CN107177630A (en) | A kind of anti-PCV2 transgene pigs preparation method without exogenous marker gene | |
CN110592122B (en) | Zebra fish naalad2 gene promoter and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191101 |